{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": false,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication via swap agreements",
        "Exposure to commodity total return index with monthly hedging",
        "Counterparty risk from issuer (UBS AG)",
        "High risk rating (7/7)",
        "No capital protection",
        "Complex exercise and redemption features",
        "Potential for total loss",
        "Use of derivative instruments inherent to product structure"
    ],
    "classification": "complex",
    "supporting_data": "The product is an Open End Tracker Certificate (ETP) issued by UBS AG, linked to the UBS CMCI Components Brent Crude GBP Monthly Hedged Total Return Index, a commodity index. The KIID explicitly states the product is not simple and may be difficult to understand, intended for investors with advanced knowledge. The product does not confer ownership rights in the underlying and relies on a predefined exercise procedure to receive redemption amounts. The underlying is a total return index with monthly hedging, implying synthetic replication through derivatives, specifically swap agreements, as the product is a debt instrument issued by UBS AG rather than a physical ETF. The risk indicator is at the highest level (7/7), reflecting significant market and issuer credit risk. The product exposes investors to counterparty risk, with no capital protection and potential for total loss. The product uses a multiplier and management fees that accrue daily, and early redemption is either not possible or costly, indicating complexity. The product\u2019s structure involves derivative instruments inherently, not merely for risk management, confirming the synthetic replication method. These factors combined meet MiFID II criteria for a complex financial instrument."
}